Julphar Julphar is one of the largest pharmaceutical manufacturers in the MEA region. The Julphar story is one of innovation and leadership.
(1)

Since our journey began in 1980, our goal has remained the same โ€“ to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, we have expanded our network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region. Headquartered in Ras Al Khaimah in the United Arab Emirates, we employ 3,400 people, and we market our products in more than 30 countries. We have 12 internationally accredited facilities that produce more than half a million medicine boxes a day, including tablets, syrups, suspensions, creams and injectables, and vaccines. Julphar has an extensive portfolio of generic medicines, branded generics, and over-the-counter medicines, as well as APIs (active pharmaceutical ingredients). We develop and manufacture medicines and supplements for everything from the common cold to diabetes.

๐—ช๐—ฒ ๐—ฎ๐—ฟ๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜๐—ผ ๐—ฎ๐—ป๐—ป๐—ผ๐˜‚๐—ป๐—ฐ๐—ฒ ๐˜๐—ต๐—ฒ ๐—น๐—ฎ๐˜‚๐—ป๐—ฐ๐—ต ๐—ผ๐—ณ ๐—ฅ๐—ถ๐˜€๐—ฒ๐—ธยฎ ๐—ฃ๐—น๐˜‚๐˜€ (๐—ข๐—บ๐—ฒ๐—ฝ๐—ฟ๐—ฎ๐˜‡๐—ผ๐—น๐—ฒ / ๐—ฆ๐—ผ๐—ฑ๐—ถ๐˜‚๐—บ ๐—•๐—ถ๐—ฐ๐—ฎ๐—ฟ๐—ฏ๐—ผ๐—ป๐—ฎ๐˜๐—ฒ) ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—ž๐—ถ๐—ป๐—ด๐—ฑ๐—ผ๐—บ ๐—ผ๐—ณ ๐—ฆ๐—ฎ๐˜‚๐—ฑ๐—ถ ๐—”๐—ฟ๐—ฎ๐—ฏ๐—ถ๐—ฎ.At J...
09/02/2026

๐—ช๐—ฒ ๐—ฎ๐—ฟ๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜๐—ผ ๐—ฎ๐—ป๐—ป๐—ผ๐˜‚๐—ป๐—ฐ๐—ฒ ๐˜๐—ต๐—ฒ ๐—น๐—ฎ๐˜‚๐—ป๐—ฐ๐—ต ๐—ผ๐—ณ ๐—ฅ๐—ถ๐˜€๐—ฒ๐—ธยฎ ๐—ฃ๐—น๐˜‚๐˜€ (๐—ข๐—บ๐—ฒ๐—ฝ๐—ฟ๐—ฎ๐˜‡๐—ผ๐—น๐—ฒ / ๐—ฆ๐—ผ๐—ฑ๐—ถ๐˜‚๐—บ ๐—•๐—ถ๐—ฐ๐—ฎ๐—ฟ๐—ฏ๐—ผ๐—ป๐—ฎ๐˜๐—ฒ) ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—ž๐—ถ๐—ป๐—ด๐—ฑ๐—ผ๐—บ ๐—ผ๐—ณ ๐—ฆ๐—ฎ๐˜‚๐—ฑ๐—ถ ๐—”๐—ฟ๐—ฎ๐—ฏ๐—ถ๐—ฎ.

At Julphar, we recognize our responsibility as a key healthcare partner in Saudi Arabia, therefore, this launch marks an important milestone in our commitment to advancing gastroenterology care and improving patient outcomes across the Kingdom.

๐—ฅ๐—ถ๐˜€๐—ฒ๐—ธยฎ Plus is designed to deliver reliable acid suppression, addressing key clinical challenges in GERD and related conditions. Its introduction adds meaningful value across the healthcare ecosystem.

As part of this launch, three scientific symposia were successfully held across the Kingdom, led by eminent experts in the field of gastroenterology. These scientific gatherings brought together healthcare professionals to:

- Discuss unmet needs in acid-related disorders.
- Review the scientific rationale behind Omeprazoleโ€“Sodium Bicarbonate combinations.
- Share real-world clinical experience and best practices.
- Reinforce evidence-based, patient-centric treatment decisions.

The launch of ๐—ฅ๐—ถ๐˜€๐—ฒ๐—ธยฎ Plus reflects our ongoing dedication to science, partnership, and patient care โ€” and it is only the beginning of what we aim to deliver to the Saudi healthcare community.

๐—ข๐—ป๐—ฒ ๐—ง๐—ฒ๐—ฎ๐—บ, ๐—ข๐—ป๐—ฒ ๐——๐—ถ๐—ฟ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป: ๐—๐˜‚๐—น๐—ฝ๐—ต๐—ฎ๐—ฟ ๐—ž๐—ฆ๐—” ๐—–๐˜†๐—ฐ๐—น๐—ฒ ๐— ๐—ฒ๐—ฒ๐˜๐—ถ๐—ป๐—ด ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐ŸฒIt was a valuable opportunity to connect, align, and strengthen c...
13/01/2026

๐—ข๐—ป๐—ฒ ๐—ง๐—ฒ๐—ฎ๐—บ, ๐—ข๐—ป๐—ฒ ๐——๐—ถ๐—ฟ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป: ๐—๐˜‚๐—น๐—ฝ๐—ต๐—ฎ๐—ฟ ๐—ž๐—ฆ๐—” ๐—–๐˜†๐—ฐ๐—น๐—ฒ ๐— ๐—ฒ๐—ฒ๐˜๐—ถ๐—ป๐—ด ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ

It was a valuable opportunity to connect, align, and strengthen collaboration across teams โ€” all within an inspiring setting that reflects both heritage and forward momentum.

When we come together, we reaffirm that real success is built on people, purpose, and our shared commitment. With renewed energy and focus, we move ahead ready to build on our achievements and embrace the year ahead.

Thank you to everyone who contributed to making this cycle meeting meaningful and memorable.

Gulf Pharmaceutical Industries - Julphar, congratulates you on the New Year, wishing you and your family a happy year fi...
31/12/2025

Gulf Pharmaceutical Industries - Julphar, congratulates you on the New Year, wishing you and your family a happy year filled with wonderful opportunities and success.

โ€Žุชู‡ู†ุฆูƒู… ุดุฑูƒุฉ ุงู„ุฎู„ูŠุฌ ู„ู„ุตู†ุงุนุงุช ุงู„ุฏูˆุงุฆูŠุฉ - ุฌู„ูุงุฑุŒ ุจุงู„ุนุงู… ุงู„ุฌุฏูŠุฏุŒ ู…ุน ุชู…ู†ูŠุงุชู†ุง ู„ูƒู… ูˆู„ุนุงุฆู„ุงุชูƒู… ุนุงู…ู‹ุง ุณุนูŠุฏู‹ุง ู…ู„ูŠุฆู‹ุง ุจุงู„ูุฑุต ุงู„ุนุธูŠู…ุฉ ูˆุงู„ู†ุฌุงุญุงุช ุงู„ุฑุงุฆุนุฉ.

At Julphar Egypt, our recent Cycle Meeting was not just a look back at results, it was a decision about the future we wa...
11/12/2025

At Julphar Egypt, our recent Cycle Meeting was not just a look back at results, it was a decision about the future we want to create together.

We aligned on a sharper path for 2026 and beyond: where we will play, how we will win, how we will accelerate strategic launches, and how we will deepen our impact for patients, partners, and healthcare professionals. But the real strategy shift is inside choosing a growth mindset as our way of working, leading, and collaborating.

Our Cultural Transformation Journey in Egypt is no longer a concept; itโ€™s visible in the courage to try new things, the ownership of results, the way teams support each other, and the belief that we can always raise the bar.

Proud of our Egypt team, proud of the ambition and even more proud of the people bringing โ€œThe Future Is Nowโ€ to life, one decision at a time. Onwards.

๐—ช๐—ฒ ๐˜„๐—ฒ๐—ฟ๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜๐—ผ ๐˜๐—ฎ๐—ธ๐—ฒ ๐—ฝ๐—ฎ๐—ฟ๐˜ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐Ÿญ๐˜€๐˜ ๐—”๐—ป๐—ป๐˜‚๐—ฎ๐—น ๐—ก๐—ฒ๐˜‚๐—ฟ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—™๐—ผ๐—ฟ๐˜‚๐—บ ๐—ณ๐—ผ๐—ฟ ๐—Ÿ๐—ถ๐—ฏ๐˜†๐—ฎ ๐—ก๐—ฒ๐˜‚๐—ฟ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐˜€๐˜๐˜€ ๐—ถ๐—ป ๐—–๐—ฎ๐—ถ๐—ฟ๐—ผThe event brought together 1...
10/12/2025

๐—ช๐—ฒ ๐˜„๐—ฒ๐—ฟ๐—ฒ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜๐—ผ ๐˜๐—ฎ๐—ธ๐—ฒ ๐—ฝ๐—ฎ๐—ฟ๐˜ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐Ÿญ๐˜€๐˜ ๐—”๐—ป๐—ป๐˜‚๐—ฎ๐—น ๐—ก๐—ฒ๐˜‚๐—ฟ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—™๐—ผ๐—ฟ๐˜‚๐—บ ๐—ณ๐—ผ๐—ฟ ๐—Ÿ๐—ถ๐—ฏ๐˜†๐—ฎ ๐—ก๐—ฒ๐˜‚๐—ฟ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐˜€๐˜๐˜€ ๐—ถ๐—ป ๐—–๐—ฎ๐—ถ๐—ฟ๐—ผ

The event brought together 10 leading neurologist key opinion Leaders, marking an important platform for scientific exchange and collaborative advancement in the field of neurology.

We were honored to have Dr. Maged Abdel Naseer, former Head of the Neurology Department at Cairo University, lead the scientific session with an insightful presentation on personalized approaches in the management of Multiple Sclerosis, highlighting the latest updates and evidence-based practices.

This forum offered a valuable opportunity to exchange expertise, strengthen regional collaboration, and keep neurologists updated with the latest scientific insights that directly support better patient care.

๐—๐˜‚๐—น๐—ฝ๐—ต๐—ฎ๐—ฟ ๐—ถ๐˜€ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜๐—ผ ๐—ฎ๐—ป๐—ป๐—ผ๐˜‚๐—ป๐—ฐ๐—ฒ ๐˜๐—ต๐—ฒ ๐˜€๐˜‚๐—ฐ๐—ฐ๐—ฒ๐˜€๐˜€๐—ณ๐˜‚๐—น ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ฒ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐˜๐—ต๐—ถ๐—ฟ๐—ฑ ๐—ฎ๐—ป๐—ฑ ๐—ณ๐—ถ๐—ป๐—ฎ๐—น ๐—ฐ๐—ผ๐—ต๐—ผ๐—ฟ๐˜ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—™๐—Ÿ๐—Ÿ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐—ฝ๐—ฟ๐—ผ๐—ด๐—ฟ๐—ฎ๐—บ.This milest...
03/12/2025

๐—๐˜‚๐—น๐—ฝ๐—ต๐—ฎ๐—ฟ ๐—ถ๐˜€ ๐—ฝ๐—ฟ๐—ผ๐˜‚๐—ฑ ๐˜๐—ผ ๐—ฎ๐—ป๐—ป๐—ผ๐˜‚๐—ป๐—ฐ๐—ฒ ๐˜๐—ต๐—ฒ ๐˜€๐˜‚๐—ฐ๐—ฐ๐—ฒ๐˜€๐˜€๐—ณ๐˜‚๐—น ๐—ฐ๐—ผ๐—บ๐—ฝ๐—น๐—ฒ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐˜๐—ต๐—ถ๐—ฟ๐—ฑ ๐—ฎ๐—ป๐—ฑ ๐—ณ๐—ถ๐—ป๐—ฎ๐—น ๐—ฐ๐—ผ๐—ต๐—ผ๐—ฟ๐˜ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—™๐—Ÿ๐—Ÿ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐—ฝ๐—ฟ๐—ผ๐—ด๐—ฟ๐—ฎ๐—บ.

This milestone underscores our ongoing commitment to developing leadership capabilities, fostering a culture of continuous growth, and promoting accountability and excellence throughout the organization.

We sincerely thank all participants for their dedication and active engagement during the program. We also extend our gratitude to the leadership team and supporting departments, whose guidance and collaboration made this initiative possible.

Together, we continue to invest in building strong leaders who will shape Julpharโ€™s future with purpose and impact.

26/11/2025

ุจุญุถูˆุฑ ุฑุฆูŠุณ ู…ุฌู„ุณ ุงู„ุฅุฏุงุฑุฉ ุงู„ุดูŠุฎ ุตู‚ุฑ ุจู† ุญู…ูŠุฏ ุงู„ู‚ุงุณู…ูŠ, ูˆุงู„ุฑุฆูŠุณ ุงู„ุชู†ููŠุฐูŠุŒ ุงู„ุณูŠุฏ ุจุงุณู„ ุฒูŠุงุฏุฉ, ุงุญุชูู„ุช ุฌู„ูุงุฑ ุจุงู„ูŠูˆู… ุงู„ูˆุทู†ูŠ ุงู„ุฑุงุจุน ูˆุงู„ุฎู…ุณูŠู† ู„ุฏูˆู„ุฉ ุงู„ุฅู…ุงุฑุงุช ุงู„ุนุฑุจูŠุฉ ุงู„ู…ุชุญุฏุฉุŒ ูˆุณุท ุฃุฌูˆุงุก ูŠู…ู„ุคู‡ุง ุงู„ูุฎุฑ ูˆุงู„ุงู†ุชู…ุงุก.

ูŠูˆู… ุชุฌุณุฏุช ููŠู‡ ุฑูˆุญ ุงู„ุงุชุญุงุฏุŒ ูˆุงูƒุชู…ู„ุช ู…ู„ุงู…ุญู‡ ุจุญุถูˆุฑ ุนุงุฆู„ุฉ ุฌู„ูุงุฑ ุงู„ุชูŠ ุดุงุฑูƒุช ู‡ุฐุง ุงู„ูˆุทู† ู…ุณูŠุฑุชู‡ุŒ ูˆุงุญุชูุช ุจุฅู†ุฌุงุฒุงุชู‡ุŒ ูˆุงุณุชุญุถุฑุช ู‚ูŠู‘ู…ู‡ ุงู„ุชูŠ ุฒุฑุนุช ููŠ ุงู„ู‚ู„ูˆุจ ู‚ุจู„ ุฃู† ุชูุฌุณุฏ ุนู„ู‰ ุฃุฑุถ ุงู„ูˆุงู‚ุน.

ุงุญุชูู„ู†ุง ุจุญูƒุงูŠุฉ ูˆุทู† ุจุฏุฃ ุญู„ู…ู‡ ุจุฑุคูŠุฉ ุทู…ูˆุญุฉุŒ ูˆุฃุตุจุญ ุงู„ูŠูˆู… ุฑู…ุฒู‹ุง ู„ู„ู†ู‡ุถุฉ ูˆุงู„ุงุฒุฏู‡ุงุฑ.

ูƒู„ ุนุงู… ูˆุฃู†ุชู… ุจุฎูŠุฑ ๐Ÿ‡ฆ๐Ÿ‡ช


Julphar Delivers Consistent Sales Growth with Stable and Resilient Profits YTD September.
14/11/2025

Julphar Delivers Consistent Sales Growth with Stable and Resilient Profits YTD September.

Julphar takes the lead in industrial sector at ๐˜๐—ต๐—ฒ ๐—จ๐—”๐—˜ ๐—Ÿ๐—ฎ๐—ฏ๐—ผ๐˜‚๐—ฟ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—”๐˜„๐—ฎ๐—ฟ๐—ฑ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ, ๐—ฎ๐—ป๐—ผ๐˜๐—ต๐—ฒ๐—ฟ ๐—บ๐—ถ๐—น๐—ฒ๐˜€๐˜๐—ผ๐—ป๐—ฒ ๐—ถ๐—ป ๐—ผ๐˜‚๐—ฟ ๐—ท๐—ผ๐˜‚๐—ฟ๐—ป๐—ฒ๐˜† ๐˜๐—ผ๐˜„๐—ฎ๐—ฟ๐—ฑ...
13/11/2025

Julphar takes the lead in industrial sector at ๐˜๐—ต๐—ฒ ๐—จ๐—”๐—˜ ๐—Ÿ๐—ฎ๐—ฏ๐—ผ๐˜‚๐—ฟ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—”๐˜„๐—ฎ๐—ฟ๐—ฑ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ, ๐—ฎ๐—ป๐—ผ๐˜๐—ต๐—ฒ๐—ฟ ๐—บ๐—ถ๐—น๐—ฒ๐˜€๐˜๐—ผ๐—ป๐—ฒ ๐—ถ๐—ป ๐—ผ๐˜‚๐—ฟ ๐—ท๐—ผ๐˜‚๐—ฟ๐—ป๐—ฒ๐˜† ๐˜๐—ผ๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€ ๐—ฎ ๐—ณ๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐˜€๐—ต๐—ฎ๐—ฝ๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—ฒ๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ!

ุฌู„ูุงุฑ ุชุชุตุฏุฑ ู‚ุทุงุน ุงู„ุตู†ุงุนุงุช ููŠ ุฌุงุฆุฒุฉ ุงู„ุฅู…ุงุฑุงุช ู„ู„ุฑูŠุงุฏุฉ ููŠ ุณูˆู‚ ุงู„ุนู…ู„ 2025, ุฎุทูˆุฉ ุฌุฏูŠุฏุฉ ููŠ ุฑุญู„ุชู†ุง ู†ุญูˆ ู…ุณุชู‚ุจู„ ูŠุตู†ุนู‡ ุงู„ุชู…ูŠุฒ!

ุดุงุฑูƒุช ุฌู„ูุงุฑ ููŠ ู…ุนุฑุถ ุงู„ุชูˆุธูŠู ุงู„ุฎุงู…ุณ ุนุดุฑ ุจุฌุงู…ุนุฉ ุฑุฃุณ ุงู„ุฎูŠู…ุฉ ู„ู„ุทุจ ูˆุงู„ุนู„ูˆู… ุงู„ุตุญูŠุฉ (RAKMHSU Career Fair 2025)ุŒ ุจู…ุดุงุฑูƒุฉ ู†ุฎุจุฉ ู…ู†...
06/11/2025

ุดุงุฑูƒุช ุฌู„ูุงุฑ ููŠ ู…ุนุฑุถ ุงู„ุชูˆุธูŠู ุงู„ุฎุงู…ุณ ุนุดุฑ ุจุฌุงู…ุนุฉ ุฑุฃุณ ุงู„ุฎูŠู…ุฉ ู„ู„ุทุจ ูˆุงู„ุนู„ูˆู… ุงู„ุตุญูŠุฉ (RAKMHSU Career Fair 2025)ุŒ ุจู…ุดุงุฑูƒุฉ ู†ุฎุจุฉ ู…ู† ุงู„ุฌู‡ุงุช ุงู„ูˆุทู†ูŠุฉ ูˆุงู„ุนุงู„ู…ูŠุฉ ููŠ ู…ุฌุงู„ุงุช ุงู„ุฑุนุงูŠุฉ ุงู„ุตุญูŠุฉ ูˆุงู„ุชุนู„ูŠู… ุงู„ุฏูˆุงุฆูŠ.

ุชุฃุชูŠ ู‡ุฐู‡ ุงู„ู…ุดุงุฑูƒุฉ ูƒุฌุฒุก ู…ู† ู…ุณูŠุฑุฉ ุฌู„ูุงุฑ ููŠ ุฏุนู… ุงู„ูƒูุงุกุงุช ูˆุชู…ูƒูŠู† ุงู„ุฃุฌูŠุงู„ ุงู„ุฌุฏูŠุฏุฉ ู…ู† ุทู„ุจุฉ ุงู„ุตูŠุฏู„ุฉ ูˆุงู„ุนู„ูˆู… ุงู„ุทุจูŠุฉุŒ ูˆุชุฒูˆูŠุฏู‡ู… ุจุฑุคูŠุฉ ุนู…ู„ูŠุฉ ุญูˆู„ ู…ุณุงุฑุงุชู‡ู… ุงู„ู…ู‡ู†ูŠุฉ ุงู„ู…ุณุชู‚ุจู„ูŠุฉ ููŠ ู‚ุทุงุน ุงู„ุตู†ุงุนุงุช ุงู„ุฏูˆุงุฆูŠุฉ.

ุฎู„ุงู„ ุงู„ุญุฏุซุŒ ู‚ุฏู… ูุฑูŠู‚ ุฌู„ูุงุฑ ู†ุจุฐุฉ ุนู† ูุฑุต ุงู„ุชุฏุฑูŠุจ ูˆุงู„ุชูˆุธูŠู ูˆุจุฑุงู…ุฌ ุงู„ุชุทูˆูŠุฑ ุงู„ุชูŠ ุชูˆูุฑู‡ุง ุงู„ุดุฑูƒุฉุŒ ู…ุคูƒุฏุฉู‹ ุญุฑุตู‡ุง ุนู„ู‰ ุงุณุชู‚ุทุงุจ ุงู„ู…ูˆุงู‡ุจ ูˆุชุฃู‡ูŠู„ ุงู„ุฌูŠู„ ุงู„ู‚ุงุฏู… ู…ู† ุงู„ุตูŠุงุฏู„ุฉ ูˆุงู„ู…ุชุฎุตุตูŠู† ููŠ ุงู„ุนู„ูˆู… ุงู„ุฏูˆุงุฆูŠุฉ.

ุชุชูˆุฌู‡ ุฌู„ูุงุฑ ุจุงู„ุดูƒุฑ ู„ุฌุงู…ุนุฉ ุฑุฃุณ ุงู„ุฎูŠู…ุฉ ู„ู„ุทุจ ูˆุงู„ุนู„ูˆู… ุงู„ุตุญูŠุฉ ุนู„ู‰ ุชู†ุธูŠู… ู‡ุฐุง ุงู„ุญุฏุซ ุงู„ู…ุชู…ูŠุฒ ุงู„ุฐูŠ ูŠุฌู…ุน ุจูŠู† ุงู„ุชุนู„ูŠู… ูˆุงู„ุงุจุชูƒุงุฑ ูˆูุฑุต ุงู„ู†ู…ูˆ ุงู„ู…ู‡ู†ูŠุŒ ู…ุคูƒุฏุฉ ุงุณุชู…ุฑุงุฑู‡ุง ููŠ ุงู„ุงุณุชุซู…ุงุฑ ููŠ ุงู„ูƒูุงุกุงุช ุงู„ุดุงุจุฉ ูˆุฏุนู… ู…ุณูŠุฑุชู‡ู… ู†ุญูˆ ู…ุณุชู‚ุจู„ ุตุญูŠ ู…ุฒุฏู‡ุฑ.

3 ู†ูˆูู…ุจุฑ | ููŠ ูŠูˆู… ุงู„ุนู„ู…ุŒ ู†ุฌุฏุฏ ููŠ ุฌู„ูุงุฑ ูุฎุฑู†ุง ูˆูˆู„ุงุกู†ุง ู„ุฑุงูŠุฉ ุฏูˆู„ุฉ ุงู„ุฅู…ุงุฑุงุช ุงู„ุนุฑุจูŠุฉ ุงู„ู…ุชุญุฏุฉุŒ ุฑู…ุฒ ุงู„ุงุชุญุงุฏ ูˆุงู„ุนุฒู‘ุฉ.ู†ุฑูุน ุงู„ุนู„ู…...
03/11/2025

3 ู†ูˆูู…ุจุฑ | ููŠ ูŠูˆู… ุงู„ุนู„ู…ุŒ ู†ุฌุฏุฏ ููŠ ุฌู„ูุงุฑ ูุฎุฑู†ุง ูˆูˆู„ุงุกู†ุง ู„ุฑุงูŠุฉ ุฏูˆู„ุฉ ุงู„ุฅู…ุงุฑุงุช ุงู„ุนุฑุจูŠุฉ ุงู„ู…ุชุญุฏุฉุŒ ุฑู…ุฒ ุงู„ุงุชุญุงุฏ ูˆุงู„ุนุฒู‘ุฉ.

ู†ุฑูุน ุงู„ุนู„ู… ุงู„ูŠูˆู… ุชุฃูƒูŠุฏุงู‹ ุนู„ู‰ ุงู„ุชุฒุงู…ู†ุง ุจู‚ูŠู… ุงู„ูˆุทู† ูˆูˆุญุฏุชู‡ุŒ ูˆุงุนุชุฒุงุฒู†ุง ุจู…ุณูŠุฑุชู‡ ุงู„ุฑูŠุงุฏูŠุฉ ุงู„ุชูŠ ุชู„ู‡ู…ู†ุง ู„ู…ูˆุงุตู„ุฉ ุงู„ุนุทุงุก ูˆุงู„ุฅู†ุฌุงุฒ.

๐—๐˜‚๐—น๐—ฝ๐—ต๐—ฎ๐—ฟ ๐—ฎ๐˜ ๐—œ๐——๐—Ÿ๐—˜๐—ฆ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ | ๐— ๐—˜๐—•๐—ข ๐—ฅ๐—ฒ๐—ฐ๐—ผ๐—ด๐—ป๐—ถ๐˜‡๐—ฒ๐—ฑ ๐—ณ๐—ผ๐—ฟ ๐—ช๐—ผ๐˜‚๐—ป๐—ฑ ๐—–๐—ฎ๐—ฟ๐—ฒ ๐—œ๐—บ๐—ฝ๐—ฎ๐—ฐ๐˜Julphar participated in the 2025 International Diabetic Low...
30/10/2025

๐—๐˜‚๐—น๐—ฝ๐—ต๐—ฎ๐—ฟ ๐—ฎ๐˜ ๐—œ๐——๐—Ÿ๐—˜๐—ฆ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ | ๐— ๐—˜๐—•๐—ข ๐—ฅ๐—ฒ๐—ฐ๐—ผ๐—ด๐—ป๐—ถ๐˜‡๐—ฒ๐—ฑ ๐—ณ๐—ผ๐—ฟ ๐—ช๐—ผ๐˜‚๐—ป๐—ฑ ๐—–๐—ฎ๐—ฟ๐—ฒ ๐—œ๐—บ๐—ฝ๐—ฎ๐—ฐ๐˜

Julphar participated in the 2025 International Diabetic Lower Extremity Symposium (IDLES), held in Bali- Indonesia, joining global experts in vascular and lower limb health. Julphar invited leading surgeons from Egypt and the GCC to attend, reflecting our commitment to advancing diabetic foot wound care.

Dynamic discussions took place, sharing knowledge and learning from the latest advancements in diabetic foot wound care, regenerative medicine, and multidisciplinary treatment approaches.

As a key highlight, MEBO received special recognition for its proven contribution to improving outcomes in diabetic foot wound care. The event reinforced Julpharโ€™s dedication to scientific progress and improving patient lives.

Address

P. O. Box 997 Airport Road, Digdaga, Ras Al Khaimah
Ras Al-Khaimah

Opening Hours

Monday 08:00 - 16:00
Tuesday 08:00 - 16:00
Wednesday 08:00 - 16:00
Thursday 08:00 - 16:00
Sunday 08:00 - 16:00

Telephone

+97172461461

Alerts

Be the first to know and let us send you an email when Julphar posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Julphar:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, was established in 1980 under the guidance of His Highness Sheikh Saqr Bin Mohammed Al Qasimi. The company employs 5,000 people and distributes a wide range of products to more than 50 countries on five continents across the globe.

Julpharโ€™s business is centered on three core units โ€“ Diabetes Solutions, General Medicines, and its consumer division, Julphar Life. The companyโ€™s product portfolio of tablets, liquids, creams and injectables target major therapeutic segments including Family Care, Gastrology, Pain and Wound Management, Antibiotic, Cardiovascular and Metabolism.